SCHEMBL8094972

SCHEMBL8094972

O=C(Nc1ccc(Cl)cc1)NS(=O)(=O)C=Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.62
ALDH1A1 P00352 4/20 0.62
MEN1 O00255 4/20 0.62
KDM4E B2RXH2 3/20 0.62
MAPT P10636 3/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
NPC1 O15118 3/20 0.62
RAB9A P51151 2/20 0.62
LMNA P02545 1/20 0.62
EGFR P00533 1/20 0.57
MMP1 P03956 1/20 0.57
MMP2 P08253 1/20 0.57
MMP9 P14780 1/20 0.57
MCL1 Q07820 1/20 0.51
HDAC1 Q13547 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
CYP3A4 P08684 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8097703 1.00 KMT2A (0.62) KMT2AALDH1A1MEN1KDM4EMAPT
SCHEMBL11538771 0.85 MAOB (0.60) KMT2AALDH1A1MEN1KDM4EMAPT
SCHEMBL11538775 0.85 MAOB (0.60) KMT2AALDH1A1MEN1KDM4EMAPT
SCHEMBL1123001 0.79 KMT2A (0.71) KMT2AALDH1A1MEN1KDM4ESMN1; SMN2
SCHEMBL11538215 0.77 MAOB (0.60) KMT2AALDH1A1MEN1MAPTSMN1; SMN2
SCHEMBL11538219 0.77 MAOB (0.60) KMT2AALDH1A1MEN1MAPTSMN1; SMN2
SCHEMBL8091307 0.76 ALDH1A1 (0.49) KMT2AALDH1A1MEN1KDM4EMAPT
SCHEMBL8097740 0.76 ALDH1A1 (0.49) KMT2AALDH1A1MEN1KDM4EMAPT
SCHEMBL11342127 0.76 KMT2A (0.49) KMT2AALDH1A1MEN1SMN1; SMN2LMNA
SCHEMBL11342126 0.76 KMT2A (0.49) KMT2AALDH1A1MEN1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed